Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 42: 1398-1404, 1996;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hietala, M.
Right arrow Articles by Palotie, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hietala, M.
Right arrow Articles by Palotie, A.

Clinical Chemistry, Vol 42, 1398-1404, Copyright © 1996 by American Association for Clinical Chemistry

DNA-based carrier screening in primary healthcare: screening for aspartylglucosaminuria mutations in maternity health offices

M Hietala, P Aula, AC Syvanen, A Isoniemi, L Peltonen and A Palotie
Department of Medical Genetics, University of Turku, Finland.

Large-scale genetic screening programs are complex enterprises in which ethical, technical, medical, and socioeconomic aspects have to be handled with professional expertise. Establishment of automated, relatively robust, and inexpensive laboratory techniques is one step of this path. Here a pilot carrier-screening program for the mutations causing aspartylglucosaminuria was carried out for pregnant women in primary care maternity health offices. Women (1975) were tested before their 12th week of pregnancy, and 31 heterozygotes were detected. The sampling was based on dried blood strips, facilitating convenient handling and inexpensive mailing to the laboratory. The mutation detection technique, solid-phase mini-sequencing simplified by the use of scintillation microplates and automated equipment, proved to be rapid, simple, inexpensive, and reliable, with a low repeat rate (2.5%). In conclusion, we found that good collaboration between the primary healthcare unit, the laboratory, and counseling experts, combined with modern laboratory technology, facilitate reliable low- cost genetic testing.


The following articles in journals at HighWire Press have cited this article:


Home page
 Antimicrob. Agents Chemother.Home page
C. Howard, A. van Daal, G. Kelly, J. Schooneveldt, G. Nimmo, and P. M. Giffard
Identification and Minisequencing-Based Discrimination of SHV {beta}-Lactamases in Nosocomial Infection-Associated Klebsiella pneumoniae in Brisbane, Australia
Antimicrob. Agents Chemother., March 1, 2002; 46(3): 659 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M Arvio, K Laiho, M Kauppi, M Peippo, P Leino, H Kautiainen, O Kaipiainen-Seppanen, and I Mononen
Carriers of the aspartylglucosaminuria genetic mutation and chronic arthritis
Ann Rheum Dis, February 1, 2002; 61(2): 180 - 181.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
T. Pastinen, M. Perola, J. Ignatius, C. Sabatti, P. Tainola, M. Levander, A.-C. Syvanen, and L. Peltonen
Dissecting a population genome for targeted screening of disease mutations
Hum. Mol. Genet., December 1, 2001; 10(26): 2961 - 2972.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
J. Emery, E. Watson, P. Rose, and A. Andermann
A systematic review of the literature exploring the role of primary care in genetic services
Fam. Pract., August 1, 1999; 16(4): 426 - 445.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association for Clinical Chemistry.